 Previous clinical trials have demonstrated that treatment with the NAP REP 2139 REP 2139-Ca results in the rapid and effective clearance ofHBsAg from the blood. This HBsAg removal has the immediate effect of unmasking the underlying, pre-existing anti-HBsAg anti-HBs response, allowing clearance of HBV virus from the blood. 